JAK2 and myeloproliferative neoplasm: Mutations affecting key components of the JAK-STAT pathway, including the driver mutations JAK2, Calreticulin (CALR), and the myeloproliferative leukemia virus oncogene (MPL), are commonly observed in MPN patients (161, 162).